{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Build for Health with Srdjan Injac","title":"Listener Questions","html":"","width":"100%","height":180,"duration":1795,"description":"A calorie deficit takes energy away. Building muscle demands it. Whether you can do both at once depends almost entirely on where you're starting from, and the answer for a beginner is not the answer for someone ten years in.\nExercise order comes next. The case for doing compound lifts first has nothing to do with those lifts being better. It's about energy: what a squat asks of you versus what a leg extension asks, and what happens to your form once the tank is empty. There are limits to that rule, and they're worth knowing before you treat it as gospel.\nThen the timeline questions. One listener has a baby on the way and a month with no gym in front of him, and wants to know when \"you don't lose it that fast\" stops being true. Another is 67. His doctor just told him muscle is the organ of longevity and to start lifting. His adult kids are terrified.\nThen the peptide mail. What an FDA advisory vote actually does, and what it doesn't. Why a yes vote is not an approval. Who pays for trials on a molecule nobody can patent, and what happens if the answer is nobody. Plus a listener six weeks into treating his own elbow, asking when \"we need more human trials\" stops being caution and starts being a gate.\n\nCorrections & Context\nWe check the big factual claims after every episode. Here's what needs fixing, what needs more context, and what held up. Everything links to a source so you can check us.\n\nWhat we got wrong\n1. You can't currently get these peptides from a compounding pharmacy. On air we described the FDA committee's vote as clearing the way for a doctor to write a prescription and a compounding pharmacy to fill it. That isn't where things stand. The Pharmacy Compounding Advisory Committee met July 23–24, 2026 and voted, but an advisory committee vote is not an agency action. Nothing has legally changed. Before any of these substances can be compounded, the FDA has to accept the recommendation and add it to the 503A Bulks List through formal notice-and-comment...","thumbnail_url":"https://img.transistorcdn.com/P6-Fwi0tU-MslFf88Jx6P5Vfzi1hBEH6zBCkjt_-K_Q/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84NTVj/NjBmNDQ2M2U1NTZm/ZTllMDc1ODIwNTk1/OWYzYi5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}